Profil
Simon Youlton worked as the Chief Scientific Officer and Head-licensing at Sinclair Pharma Plc from 2010 to 2011.
He also worked as the Chief Scientific Officer at Sinclair Pharma Ltd.
Anciens postes connus de Simon Youlton
Sociétés | Poste | Fin |
---|---|---|
Sinclair Pharma Plc /Old/
Sinclair Pharma Plc /Old/ Pharmaceuticals: MajorHealth Technology Sinclair Pharma Plc is a specialty pharmaceutical company. It provides solutions to treat wounds, which include skin disinfection, radiation dermatitis treatment and wounds and burns healing; dermatology, which include fungal infections, acne, atopic dermatitis and family dermatology; as well as oral diseases, which include gingivitis, periodontitis, mouth ulcers and teething through advanced surface technology and innovative delivery systems. The company was founded by Andrew Sinclair in 1971 and is headquartered in Godalming, the United Kingdom. | Directeur Technique/Scientifique/R&D | 27/06/2011 |
SINCLAIR PHARMA PLC | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Sinclair Pharma Plc /Old/
Sinclair Pharma Plc /Old/ Pharmaceuticals: MajorHealth Technology Sinclair Pharma Plc is a specialty pharmaceutical company. It provides solutions to treat wounds, which include skin disinfection, radiation dermatitis treatment and wounds and burns healing; dermatology, which include fungal infections, acne, atopic dermatitis and family dermatology; as well as oral diseases, which include gingivitis, periodontitis, mouth ulcers and teething through advanced surface technology and innovative delivery systems. The company was founded by Andrew Sinclair in 1971 and is headquartered in Godalming, the United Kingdom. | Health Technology |
Sinclair Pharma Ltd.
Sinclair Pharma Ltd. Medical SpecialtiesHealth Technology Sinclair Pharma Ltd. operates as an aesthetic dermatology company which provides solutions through collagen stimulation for facial volume loss, thread lifting for facial contouring, and dermal fillers for wrinkles and lines. It operates through the following business segments: Country Operations and International Operations. The Country Operations segment comprises the proprietary sales infrastructure from the operations in France, the United Kingdom, Italy, Germany, and Spain. The International Operations segment focuses on the sale through a local distributor. The company was founded in 1971 and is headquartered in London, the United Kingdom. | Health Technology |